🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Rebecca Y. Bellis

ORCID: 0000-0002-4219-0733

MedicineBiochemistry, Genetics and Molecular BiologyImmunology and MicrobiologyEngineering

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 6 papers. Top paper: “Correlative analysis from a phase I clinical trial of intrapleural administration of oncolytic vaccinia virus (Olvi-vec) in patients with malignant pleural mesothelioma”.

Correlative analysis from a phase I clinical trial of intrapleural administration of oncolytic vaccinia virus (Olvi-vec) in patients with malignant pleural mesothelioma

Frontiers in Immunology(2023)10.3389/fimmu.2023.1112960

N/A

0.901DataRank · unranked

30 citations

Jennie K. Choe, Erin McGee, Rebecca Y. Bellis, Jasmeen Saini, Srijita Banerjee +5 more

Imaging CAR T-cell kinetics in solid tumors: Translational implications

Molecular Therapy — Oncolytics(2021)10.1016/j.omto.2021.06.006

N/A

0DataRank · unranked

47 citations

Hocine R. Hocine, Jasmeen Saini, Maxim A. Moroz, Rebecca Y. Bellis, Srijita Banerjee +5 more

CAR T-cell therapy for pleural mesothelioma: Rationale, preclinical development, and clinical trials

Lung Cancer(2021)10.1016/j.lungcan.2021.05.004

N/A

0DataRank · unranked

33 citations

David Restle, Hue Tu Quach, Jasmeen Saini, Rebecca Y. Bellis, Michael Offin +3 more

Next-generation immunotherapy for solid tumors: combination immunotherapy with crosstalk blockade of TGFβ and PD-1/PD-L1

Expert Opinion on Investigational Drugs(2022)10.1080/13543784.2022.2152323

N/A

0DataRank · unranked

7 citations

Zhaohua Hou, Rebecca Y. Bellis, Jasmeen Saini, Alfredo Amador-Molina, Prasad S. Adusumilli +2 more

Tumor-Targeted Nonablative Radiation Promotes Solid Tumor CAR T-cell Therapy Efficacy

Cancer Immunology Research(2023)10.1158/2326-6066.cir-22-0840

N/A

0DataRank · unranked

29 citations

Matthew S. Skovgard, Jonathan Villena‐Vargas, Rebecca Y. Bellis, Navin K. Chintala, Alfredo Amador-Molina +16 more

DLL3-targeted CAR T-cell therapy in pre-clinical models for small cell lung cancer: safety, efficacy, and challenges

Translational Lung Cancer Research(2024)10.21037/tlcr-23-820

N/A

0DataRank · unranked

5 citations

Prasad S. Adusumilli, Alfredo Amador-Molina, Rebecca Y. Bellis